Publications of B. Müller-Myhsok
All genres
Journal Article (385)
341.
Journal Article
67 (7), pp. 1262 - 1264 (2006)
Creatine supplementation in Parkinson disease: A placebo-controlled randomized pilot trial. Neurology 342.
Journal Article
141B (7), pp. 739 - 740 (2006)
An association candidate-gene study on genetic variations within HTR2A in patients suffering from panic disorder. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 343.
Journal Article
67 (2), pp. 320 - 321 (2006)
RLS3: Fine-mapping of an autosomal dominant locus in a family with intrafamilial heterogeneity. Neurology 344.
Journal Article
12 (7), pp. 606 - 611 (2006)
Role of the NFKB1-94ins/delATTG promoter polymorphism in IBD and potential interactions with Polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes. Inflammatory Bowel Diseases 345.
Journal Article
43 (7), pp. 557 - 562 (2006)
The sepiapterin reductase gene region reveals association in the PARK3 locus: analysis of familial and sporadic Parkinson's disease in European populations. Journal of Medical Genetics 346.
Journal Article
141B (4), pp. 374 - 382 (2006)
Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 347.
Journal Article
16 (Suppl. 1), p. S75 - S75 (2006)
SNPs in FKBP5 determine a novel subtype of depression characterized by rapid response to antidepressant treatment. European Neuropsychopharmacology 348.
Journal Article
16 (Suppl. 1), p. S88 - S88 (2006)
Possible genetic implications of the endo-cannabinoid system in anxiety disorders versus depressive disorders. European Neuropsychopharmacology 349.
Journal Article
11, pp. 1003 - 1015 (2006)
Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism. Molecular Psychiatry 350.
Journal Article
15 (16), pp. 2438 - 2445 (2006)
P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Human Molecular Genetics 351.
Journal Article
21 (1), pp. 28 - 33 (2006)
Evidence for further genetic locus heterogeneity and confirmation of RLS-1 in restless legs syndrome. Movement Disorders 352.
Journal Article
11 (12), pp. 1031 - 1037 (2005)
Association of polymorphisms in the interleukin-18 gene in patients with Crohn's disease depending on the CARD15/NOD2 genotype. Inflammatory Bowel Diseases 353.
Journal Article
69, p. 771 - 771 (2005)
SimPed: A simulation program to generate haplotype and genotype data for pedigree structures. Annals of Human Genetics 354.
Journal Article
69, pp. 772 - 773 (2005)
Rapid simulation of p-values for product methods and multiple-testing adjustment in association studies. Annals of Human Genetics 355.
Journal Article
54 (10), pp. 1421 - 1427 (2005)
Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. Gut 356.
Journal Article
138B (1), p. 82 - 82 (2005)
A glutamine to arginine mutation in the C-terminal domain of P2RX7 determines the risk for mood disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 357.
Journal Article
138B (1), p. 44 - 44 (2005)
Genetic implications of the endocannabinoid system in anxiety disorders versus depressive disorders: Is there any evidence for the continuum hypothesis? American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 358.
Journal Article
138B (1), p. 48 - 48 (2005)
The cortisol and ACTH response in the combined Dex/CRH test of acutely depressed patients varies significantly between 5-HT2A receptor genotypes. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 359.
Journal Article
138B (1), p. 45 - 45 (2005)
Syndromal panic attacks are possibly associated with polymorphisms in the angiotensin converting enzyme (ACE) gene. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 360.
Journal Article
38 (5), p. 240 - 240 (2005)
Genetic implications of the endocannabinoid system in anxiety disorders versus depressive disorders: is there any evidence for the continuum hypothesis? Pharmacopsychiatry